Medience

Medience Co., Ltd. is a South Korean life science company specializing in infant healthcare, functional bio-materials, and microbiome-based therapeutics. Formerly known as Boryung Medience, the company rebranded in 2021 to reflect its strategic pivot toward advanced biotechnology and research-driven healthcare solutions. Medience operates a dedicated Microbiome Research Center focused on developing microbial therapies for immune-related conditions, such as atopic dermatitis, and enhancing pediatric health through targeted probiotics. Additionally, the company is a major supplier of high-purity raw materials, including pseudo-ceramides and fermented extracts, for the global pharmaceutical and dermo-cosmetic industries. Medience is publicly traded on the KOSDAQ exchange and maintains a leadership position in the Asian specialty healthcare market.